Sørensen H A, Schwarz P, McNair P, Hyldstrup L, Transbøl I
Department of Internal Medicine, Hvidovre Hospital, Denmark.
Scand J Clin Lab Invest. 1992 Oct;52(6):457-65. doi: 10.3109/00365519209090122.
The aim of the study was to investigate the interrelation between induced hypercalcaemia and serum intact parathyroid hormone (S-PTH(1-84)) in normal man and in patients with primary hyperparathyroidism (PHPT) by measuring blood ionized calcium (B-Ca++) and S-PTH(1-84) before and during a controlled calcium infusion. Guided by frequent measurements of B-Ca++, we adjusted the calcium infusion rate continuously, thereby keeping B-Ca++ in a steady state at a pre-determined level approximately 0.25 mmol l-1 above baseline values. This calcium clamp technique (CCT) applied to 14 normal volunteers for 120 min established a standardized reference for parathyroid suppression and the renal physiological PTH response. The reproducibility of the method and the results obtained by the CCT were satisfactorily assessed in six of the 14 normal subjects. In normal subjects B-Ca++ was raised from 1.25 +/- 0.3 mmol l-1 (mean +/- SD) to 1.49 +/- 0.02 mmol l-1 suppressing S-PTH(1-84) to 264 +/- 9.9% of pre-infusion levels. We applied the CCT to 10 patients with PHPT for 120 min raising B-Ca++ from 1.41 +/- 0.09 mmol l-1 to 1.69 +/- 0.08 mmol l-1, thereby suppressing S-PTH(1-84) to 47.9 +/- 16.3% of pre-infusion levels. The renal handling of calcium and phosphate during CCT demonstrates the biological effects of suppressed activity of PTH on the renal tubules showing increments in the maximal tubular phosphate reabsorption in relation to the glomerular filtration rate (TmP/GFR) and decreased tubular reabsorption fraction of calcium. The described CCT is a safe and reliable dynamic test.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究的目的是通过在控制性钙输注前后测量血离子钙(B-Ca++)和血清完整甲状旁腺激素(S-PTH(1-84)),来研究正常人和原发性甲状旁腺功能亢进症(PHPT)患者中诱导性高钙血症与血清完整甲状旁腺激素之间的相互关系。在频繁测量B-Ca++的指导下,我们持续调整钙输注速率,从而使B-Ca++在稳态下维持在比基线值高约0.25 mmol l-1的预定水平。这种钙钳技术(CCT)应用于14名正常志愿者120分钟,建立了甲状旁腺抑制和肾脏生理性甲状旁腺激素反应的标准化参考。在14名正常受试者中的6名中,对该方法的可重复性以及CCT获得的结果进行了令人满意的评估。在正常受试者中,B-Ca++从1.25±0.3 mmol l-1(平均值±标准差)升至1.49±0.02 mmol l-1,将S-PTH(1-84)抑制至输注前水平的264±9.9%。我们将CCT应用于10名PHPT患者120分钟,使B-Ca++从1.41±0.09 mmol l-1升至1.69±0.08 mmol l-1,从而将S-PTH(1-84)抑制至输注前水平的47.9±16.3%。CCT期间钙和磷的肾脏处理显示了甲状旁腺激素活性受抑制对肾小管的生物学效应,表现为相对于肾小球滤过率(TmP/GFR)的最大肾小管磷重吸收增加,以及钙的肾小管重吸收分数降低。所描述的CCT是一种安全可靠的动态试验。(摘要截断于250字)